Collectively, the deletion of β-catenin could effectively inhibit menin deficiency-driven β-cell proliferation and significantly improve the insulinoma-induced severe hyperinsulinemia and hypoglycemia in Men1-deficient mice. The gene discussed is MEN1; the disease is pancreatic insulinoma.